Location History:
- Research Triangle Park, NC (US) (2020 - 2021)
- Hamilton, MT (US) (2022)
Company Filing History:
Years Active: 2020-2022
Title: Michael Cochran: Innovator in Immunogenic Therapies
Introduction
Michael Cochran is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of immunology, particularly through his innovative work on vaccine adjuvants. With a total of 3 patents to his name, Cochran's inventions are paving the way for advancements in therapeutic applications.
Latest Patents
Cochran's latest patents include groundbreaking work on imidazoquinoline derivatives and their use in therapy. This invention focuses on novel imidazoquinoline derivatives that serve as vaccine adjuvants, enhancing the efficacy of vaccines. Another significant patent involves immunogenic compositions and methods for producing them, specifically those comprising a protein antigen cross-linked to an oxoadenine adjuvant. These innovations are crucial for developing more effective immunogenic therapies.
Career Highlights
Throughout his career, Michael Cochran has been associated with GlaxoSmithKline Biologicals SA, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of immunogenic responses and the development of new therapeutic strategies.
Collaborations
Cochran has collaborated with esteemed colleagues, including David Burkhart and Helene G Bazin-Lee. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries in the field of immunology.
Conclusion
Michael Cochran's contributions to immunogenic therapies through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of new therapeutic approaches, making a significant impact on public health.